
|Articles|January 31, 2015
Joel Schuman, MD, discusses Glaucoma 360 and the Catalyst for a Cure
Joel Schuman, MD, FACS, director of the UPMC Eye Center at the University of Pittsburgh, discusses the upcoming Glaucoma 360 meeting and the Catalyst for a Cure. The meeting is planned for Feb. 5-7 in San Francisco. Both programs are part of Glaucoma Research Foundation's mission to prevent vision loss from glaucoma by investing in innovative research.
Advertisement
Joel Schuman, MD, FACS, director of the UPMC Eye Center at the University of Pittsburgh, discusses the upcoming Glaucoma 360 meeting and the Catalyst for a Cure. The meeting is planned for Feb. 5-7 in San Francisco. Both programs are part of Glaucoma Research Foundation's mission to prevent vision loss from glaucoma by investing in innovative research.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Recognizing biomarkers of Alzheimer Disease using OCTA
2
Midyear cataract check-in: What 2026 has brought to the OR and beyond
3
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
4
Durability With Aflibercept 8 mg in Retinal Vascular Diseases
5





















